Mirae Asset Global Investments
HCAT icon

Mirae Asset Global Investments’s Health Catalyst HCAT Stock Holding History

Mirae Asset Global Investments’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,818
Closed -$291K – 1967
2024
Q1 		$291K Hold
25,818
– – ﹤0.01% 2120
2023
Q4 		$239K Hold
25,818
– – ﹤0.01% 2280
2023
Q3 		$261K Hold
25,818
– – ﹤0.01% 2194
2023
Q2 		$323K Hold
25,818
– – ﹤0.01% 2150
2023
Q1 		$301K Hold
25,818
– – ﹤0.01% 2166
2022
Q4 		$274K Buy
25,818
+3,124
+14% +$30.2K ﹤0.01% 2188
2022
Q3 		$220K Buy
22,694
+7,774
+52% +$103K ﹤0.01% 2301
2022
Q2 		$216K Buy
+14,920
New +$254K ﹤0.01% 2123

Other funds holding HCAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return